Literature DB >> 21229319

Disorders of bile acid synthesis.

Peter Theodore Clayton1.   

Abstract

Inborn errors of bile acid synthesis can produce life-threatening cholestatic liver disease (which usually presents in infancy) and progressive neurological disease presenting later in childhood or in adult life. Both types of disease can often be treated very effectively with bile acid replacement therapy and it is therefore important to diagnose these disorders as early as possible. The cholestatic disease in infancy is characterised by conjugated hyperbilirubinaemia with raised transaminases but normal γ-glutamyl transpeptidase and a biopsy showing a giant cell hepatitis. There is usually evidence of fat-soluble vitamin malabsorption. The neurological presentation often includes signs of upper motor neurone damage (spastic paraparesis). The most useful screening test for many of these disorders is analysis of urinary cholanoids (bile acids and bile alcohols); this is usually now achieved by electrospray ionisation tandem mass spectrometry. The disorders that are discussed in this review are: 3β-hydroxysteroid-Δ5-C27-steroid dehydrogenase deficiency, Δ4-3-oxosteroid 5β-reductase deficiency, sterol 27-hydroxylase deficiency (cerberotendinous xanthomatosis, CTX), oxysterol 7α-hydroxylase deficiency (including one form of hereditary spastic paraparesis) and the amidation defects, bile acid-CoA: aminoacid N-acyltransferase (BAAT) deficiency and bile acid-CoA ligase deficiency. The disorders of peroxisome biogenesis and peroxisomal β-oxidation that affect bile acid synthesis will be covered in the review by Ferdinandusse et al.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21229319     DOI: 10.1007/s10545-010-9259-3

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  51 in total

Review 1.  Do oxysterols control cholesterol homeostasis?

Authors:  Ingemar Björkhem
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

2.  Bile acids and bile alcohols in a child with hepatic 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency: effects of chenodeoxycholic acid treatment.

Authors:  H Ichimiya; B Egestad; H Nazer; E S Baginski; P T Clayton; J Sjövall
Journal:  J Lipid Res       Date:  1991-05       Impact factor: 5.922

3.  White matter lesions in spastic paraplegia with mutations in SPG5/CYP7B1.

Authors:  Roberta Biancheri; Marianna Ciccolella; Andrea Rossi; Alessandra Tessa; Denise Cassandrini; Carlo Minetti; Filippo M Santorelli
Journal:  Neuromuscul Disord       Date:  2009-01       Impact factor: 4.296

4.  Neonatal cholestatic liver disease in an Asian patient with a homozygous mutation in the oxysterol 7alpha-hydroxylase gene.

Authors:  Isao Ueki; Akihiko Kimura; Atsushi Nishiyori; Huey-Ling Chen; Hajime Takei; Hiroshi Nittono; Takao Kurosawa
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-04       Impact factor: 2.839

5.  Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease.

Authors:  Jeffrey B Cheng; Emmanuel Jacquemin; Marie Gerhardt; Hisham Nazer; Danièle Cresteil; James E Heubi; Kenneth D R Setchell; David W Russell
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

6.  The metabolism of 3alpha, 7alpha, 12alpha-trihydorxy-5beta-cholestan-26-oic acid in two siblings with cholestasis due to intrahepatic bile duct anomalies. An apparent inborn error of cholic acid synthesis.

Authors:  R F Hanson; J N Isenberg; G C Williams; D Hachey; P Szczepanik; P D Klein; H L Sharp
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

7.  CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5.

Authors:  Cyril Goizet; Amir Boukhris; Alexandra Durr; Christian Beetz; Jeremy Truchetto; Christelle Tesson; Maria Tsaousidou; Sylvie Forlani; Lucie Guyant-Maréchal; Bertrand Fontaine; João Guimarães; Bertrand Isidor; Olivier Chazouillères; Dominique Wendum; Djamel Grid; Françoise Chevy; Patrick F Chinnery; Paula Coutinho; Jean-Philippe Azulay; Imed Feki; Fanny Mochel; Claude Wolf; Chokri Mhiri; Andrew Crosby; Alexis Brice; Giovanni Stevanin
Journal:  Brain       Date:  2009-05-12       Impact factor: 13.501

8.  Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat.

Authors:  Vladimir M Berginer; Bella Gross; Khayat Morad; Nechama Kfir; Siman Morkos; Salameh Aaref; Tzipora C Falik-Zaccai
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

9.  Human Delta4-3-oxosteroid 5beta-reductase (AKR1D1) deficiency and steroid metabolism.

Authors:  Mario Palermo; Maria Grazia Marazzi; Beverly A Hughes; Paul M Stewart; Peter T Clayton; Cedric H L Shackleton
Journal:  Steroids       Date:  2007-12-14       Impact factor: 2.668

10.  A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain.

Authors:  T Setoguchi; G Salen; G S Tint; E H Mosbach
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

View more
  46 in total

1.  Liver disease in infancy caused by oxysterol 7 α-hydroxylase deficiency: successful treatment with chenodeoxycholic acid.

Authors:  Dongling Dai; Philippa B Mills; Emma Footitt; Paul Gissen; Patricia McClean; Jens Stahlschmidt; Isabelle Coupry; Julie Lavie; Fanny Mochel; Cyril Goizet; Tatsuki Mizuochi; Akihiko Kimura; Hiroshi Nittono; Karin Schwarz; Peter J Crick; Yuqin Wang; William J Griffiths; Peter T Clayton
Journal:  J Inherit Metab Dis       Date:  2014-09       Impact factor: 4.982

2.  Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis.

Authors:  Stefano Fiorucci; Eleonora Distrutti; Michele Biagioli
Journal:  Dig Dis Sci       Date:  2021-02-08       Impact factor: 3.199

Review 3.  Inborn errors of metabolism in the differential diagnosis of fatty liver disease.

Authors:  Yılmaz Yıldız; Hatice Serap Sivri
Journal:  Turk J Gastroenterol       Date:  2020-01       Impact factor: 1.852

Review 4.  Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy.

Authors:  Spencer P Larson; Oormila Kovilam; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2015-10-15       Impact factor: 4.473

5.  [Clinical feature and genetic analysis of a family affected by congenital bile acid synthesis defect type 2: identification of 2 novel mutations in AKR1D1 gene].

Authors:  Ying Cheng; Li Guo; Mei Deng; Yuan-Zong Song
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-07

6.  Two neonatal cholestasis patients with mutations in the SRD5B1 (AKR1D1) gene: diagnosis and bile acid profiles during chenodeoxycholic acid treatment.

Authors:  Yoshitaka Seki; Tatsuki Mizuochi; Akihiko Kimura; Tomoyuki Takahashi; Akira Ohtake; Shin-Ichi Hayashi; Toshiya Morimura; Yasuharu Ohno; Takayuki Hoshina; Kenji Ihara; Hajime Takei; Hiroshi Nittono; Takao Kurosawa; Keiko Homma; Tomonobu Hasegawa; Toyojiro Matsuishi
Journal:  J Inherit Metab Dis       Date:  2012-11-16       Impact factor: 4.982

7.  ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment.

Authors:  Sílvia Vilarinho; Sinan Sari; Francesca Mazzacuva; Kaya Bilgüvar; Güldal Esendagli-Yilmaz; Dhanpat Jain; Gülen Akyol; Buket Dalgiç; Murat Günel; Peter T Clayton; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

8.  RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice.

Authors:  Hong Lu; Sumedha Gunewardena; Julia Y Cui; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-02-04       Impact factor: 3.922

9.  Primary ∆4-3-oxosteroid 5β-reductase deficiency: two cases in China.

Authors:  Jing Zhao; Ling-Juan Fang; Kenneth D R Setchell; Rui Chen; Li-Ting Li; Jian-She Wang
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 10.  Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters.

Authors:  M Sawkat Anwer; Bruno Stieger
Journal:  Pflugers Arch       Date:  2013-10-03       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.